Oncological Disease
 European School of Haematology    Multinational Association of Supportive Care in Cancer    The European Organisation for the Research and Treatment of Cancer    European Society of Gynaecological Oncology 
Username: Password:
searchsite
 
Oncological Disease » Genitourinary Cancer »
Tuesday, 13 May, 2008


Browse by Topic
» Brain Tumor » Breast Cancer » Cervical Cancer » Colorectal Cancer » Endometrial Cancer » Gastrointestinal Cancer » Genitourinary Cancer » Leukemia » Lung Cancer » Ovarian Cancer

Genitourinary Cancer
Acrylamide in Diet: Cancer Risk?
Mouth Swab May One Day Diagnose Lung Cancer
Now-Banned Hair Dyes Linked to Bladder Cancer
Caregiving

Hot Topic
Radical Cystectomy Best for Most High-Risk Bladder Cancer Patients
Oct. 1, 2007
Researchers are zeroing in on which treatment is best for high-risk bladder cancer. For most with high-risk T1G3 disease, radical cystectomy is the answer, suggest study findings published in the September 25 issue of PloS Medicine.


Keeping you up to date with the latest clinical trial information

Toilet rolls

Tumour Markers in Bladder Cancer


Each year more than 50,000 and 24,000 new bladder cancers are diagnosed in the US and in Germany respectively. Download PDF

Global Trial Bank

Beyond Trial Registration: A Global Trial Bank for Clinical Trial Reporting


Clinical trials are one of the most valuable sources of evidence to determine which therapies are safe and effective. However, instances of selective reporting of results to benefit proprietary interests rather than public health have recently come to light. Download PDF

Bottle of pills

Getting It Right: Being Smarter about Clinical Trials


Concerns about adverse events, including deaths, in recent large clinical trials, both publicly and privately sponsored, prompted Elias A. Zerhouni, Director, National Institutes of Health (NIH) to convene a meeting at the NIH Download PDF
Newly FDA-approved drugs

Nexavar (sorafenib) Tablets
Company: Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals, Inc.
Approved: December 20, 2005
Approvals process Treatment for: Advanced Renal Cell Carcinoma
Nexavar is an oral multi-kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma (RCC), or kidney cancer.
Guidelines Watch
A round up of the latest Clinical Guidelines from the National Guideline Clearinghouse (NGC)

Pretreatment staging of invasive bladder cancer


Regulatory Alert

Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging (MRI)

September 28, 2007, Manufacturers of Gadolinium-based contrast agents issued a Dear Healthcare Professional letter to inform healthcare professionals of the addition of a BOXED WARNING and revisions to the WARNING section of the prescribing information for Gadolinium-based contrast agents as listed above used in Magnetic Resonance Imaging (MRI).

May 23, 2007, Gadolinium-based Contrast Agents: The addition of a boxed warning and new warnings about the risk of nephrogenic systemic fibrosis (NSF) to the full prescribing information for all gadolinium-based contrast agents (GBCAs).


Upcoming Events
Cancer Epigenetics
28 -  31 May 2008
Boston Park Plaza Hotel, Boston, USA
2008 ASCO Annual Meeting
30 May -  03 Jun 2008
McCormick Place, Chicago, USA
ASCO Annual Meeting
30 May -  03 Jun 2008
McCormick Place, Chicago, USA


Further Reading
Other Articles from Touch
Pediatric Urologic Oncology
Tumour Markers in Bladder Cancer

Events
2008 ASCO Annual Meeting
May 30-June 3, 2008

  Copyright Touch Briefings 2005 - 2008    Terms & Conditions | Privacy Statement|

Articles : a b c d e f g h i j k l m n o p q r s t u v w x y z
Companies : a b c d e f g h i j k l m n o p q r s t u v w x y z
Events : a b c d e f g h i j k l m n o p q r s t u v w x y z
Keywords : a b c d e f g h i j k l m n o p q r s t u v w x y z

Specialities :
Brain Tumor Breast Cancer Cervical Cancer Colorectal Cancer Endometrial Cancer Gastrointestinal Cancer Genitourinary Cancer Leukemia Lung Cancer Ovarian Cancer

Other Touch Group sites:   
Cardiology - Endocrine Disease - Oncological Disease - Gastroenterology - Respiratory Disease